Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. - McEvoy,J.P.; Meyer,J.M.; Goff,D.C.; Nasrallah,H.A.; Davis,S.M.; Sullivan,L.; Meltzer,H.Y.; Hsiao,J.; Stroup,T.S.; Lieberman,J.A. (Schizophr Res, 2005)